Inventor · disambiguated record
Chul-Yong Park
Also filed as: PARK CHUL-YONG
7 granted patents·1 pending application·23 citations·filing 2010–2021
78Inventor score
Files withUNIV YONSEI IACF3EWHA UNIVERSITY-INDUSTRY COLLABORATION FOUND2KIM DAE-KEE2INST BASIC SCIENCE1
Top patents by PatentIndex Score
8 records- 0184US8080568B12-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitorsKIM DAE-KEE·Filed 2010·Granted Dec 20, 2011·18 cites·3 claims
- 0272USRE47141EMethods of treating fibrosis, cancer and vascular injuriesEWHA UNIVERSITY—INDUSTRY COLLABORATION FOUND·Filed 2016·Granted Nov 27, 2018·1 cites·51 claims
- 0367USRE47122E2-pyridyl substituted imidazoles as therapeutic ALK5 and/or ALK4 inhibitorsEWHA UNIVERSITY—INDUSTRY COLLABORATION FOUND·Filed 2016·Granted Nov 13, 2018·1 cites·18 claims
- 0464US8513222B2Methods of treating fibrosis, cancer and vascular injuriesKIM DAE-KEE·Filed 2011·Granted Aug 20, 2013·3 cites·6 claims
- 0562US11202839B2RNA guided endonuclease targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising sameUNIV YONSEI IACF·Filed 2017·Granted Dec 21, 2021·0 cites·8 claims
- 0661US11197935B2Talen targeting blood coagulation factor VIII intron 1 inversion gene and composition for treating hemophilia comprising sameUNIV YONSEI IACF·Filed 2017·Granted Dec 14, 2021·0 cites·11 claims
- 0759US2024018492A1Prime editing using hiv reverse transcriptase and cas9 or variant thereofINST BASIC SCIENCE·Filed 2021·Application pending·0 cites
- 0857US11185596B2Endonuclease targeting blood coagulation factor VIII gene and composition for treating hemophilia comprising sameUNIV YONSEI IACF·Filed 2016·Granted Nov 30, 2021·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Chul-Yong Park files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →